chr17-18263216-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_139162.4(MIEF2):āc.278T>Cā(p.Val93Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000535 in 1,613,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_139162.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIEF2 | NM_139162.4 | c.278T>C | p.Val93Ala | missense_variant | 3/4 | ENST00000323019.9 | NP_631901.2 | |
MIEF2 | NM_148886.2 | c.311T>C | p.Val104Ala | missense_variant | 3/4 | NP_683684.2 | ||
MIEF2 | NM_001144900.3 | c.278T>C | p.Val93Ala | missense_variant | 3/4 | NP_001138372.1 | ||
MIEF2 | XM_017024190.2 | c.299T>C | p.Val100Ala | missense_variant | 3/4 | XP_016879679.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIEF2 | ENST00000323019.9 | c.278T>C | p.Val93Ala | missense_variant | 3/4 | 2 | NM_139162.4 | ENSP00000323591.4 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000159 AC: 40AN: 251066Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135854
GnomAD4 exome AF: 0.000565 AC: 826AN: 1461504Hom.: 0 Cov.: 32 AF XY: 0.000523 AC XY: 380AN XY: 727042
GnomAD4 genome AF: 0.000243 AC: 37AN: 152362Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2023 | The c.311T>C (p.V104A) alteration is located in exon 3 (coding exon 3) of the MIEF2 gene. This alteration results from a T to C substitution at nucleotide position 311, causing the valine (V) at amino acid position 104 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at